Vikas Lifecare Limited (VIKASLIFE) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹2.7B
Fair value as of: Jul 4, 2026
From 17 valuation models · updated today
Share price −2.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹1.06 – ₹2.59 · fair‑value band ₹1.93 – ₹2.18 · the ₹1.45 price screens below the ₹2.18 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Vikas Lifecare Limited (VIKASLIFE) currently trades at ₹1.45, while our model-based Fair Value estimate is ₹2.18 — implying the stock looks roughly 50.3% undervalued today. We read business quality at 54/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Vikas Lifecare Limited generated revenue of ₹5.0B at a net margin of 3.7%. Revenue grew 24.7% year over year. It earns a return on equity of 3.4%. Net debt stands at ₹1.0B. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Vikas Lifecare Limited engages in manufacturing and trading of polymers, chemicals, iron and steel, and plastic products in India and Ghana. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure segments. It offers various polymer compounds, including PE compounds, PVC compounds, V blend SOE compounds, polypropylene compounds, and thermo plastic rubber (TPR) compounds. The company is involved in developing smart products comprising smart gas and water meters, and power distribution solutions; supplying of food grade piping systems for drinking water; infrastructure products consisting of drinking water pipes, fittings, and bars; trading of agro products, including rice and pulses; dealing in raw and finished cashew nuts, dry fruits, and other premium consumer products. In addition, it engages in research and development of horticultural, cultivation, and …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Vikas Lifecare Limited reported revenue of ₹5.0B in FY2026 versus ₹3.0B in FY2022, a compound +13.5%/yr. Reported net income was ₹184M in FY2026, compounding −10.5%/yr from FY2022.
Is VIKASLIFE fairly valued? → Check now
Similar stocks
6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $83.37 | $35.54 | -57% |
| MHP SE MHPC | $0.0854 | $0.0100 | -88% |
| Muyuan Foods Group 002714 | ¥33.95 | ¥119.07 | +251% |
| Bunge Global SA BG | $129.13 | $136.85 | +6% |
| Tyson Foods, Inc TSN | $55.51 | $46.40 | -16% |
| Wens Foodstuff Group 300498 | ¥12.89 | ¥6.35 | -51% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Vikas Lifecare Limited (VIKASLIFE) undervalued?
What is the fair value of VIKASLIFE?
What is the quality score of VIKASLIFE?
What is the revenue of Vikas Lifecare Limited (VIKASLIFE)?
What is the net profit margin of VIKASLIFE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.